Bifunctional T cell engagers exhibiting specificity for the GBM tumor cell surface antigen CD133 (48)/EGFRvIII (49, 50) have also been shown to induce anti-tumorigenic activity in xenograft tumor models. Here, PROM1 is linked to glioblastoma.